CEO Peter Baccile highlighted a successful 2024, driven by strong cash rental rate growth and the second-highest year for development lease signings since 2012. For 2025, the company expects FFO ...
Q4 2024 Management View Labcorp reported revenue of $3.3 billion for Q4 2024, an increase of 10% year-over-year, with Diagnostics and Biopharma segments each posting 10% growth. Chairman and CEO Adam ...
CFO David Johnson reported that organic sales in Q4 2024 increased by 13%, with 16% growth in Seed and 11% in Crop Protection. Volume growth was strong, particularly in Latin America. Operating EBITDA ...